Literature DB >> 21878628

Hck is a key regulator of gene expression in alternatively activated human monocytes.

Ashish Bhattacharjee1, Srabani Pal, Gerald M Feldman, Martha K Cathcart.   

Abstract

IL-13 is a Th2 cytokine that promotes alternative activation (M2 polarization) in primary human monocytes. Our studies have characterized the functional IL-13 receptor complex and the downstream signaling events in response to IL-13 stimulation in alternatively activated monocytes/macrophages. In this report, we present evidence that IL-13 induces the activation of a Src family tyrosine kinase, which is required for IL-13 induction of M2 gene expression, including 15-lipoxygenase (15-LO). Our data show that Src kinase activity regulates IL-13-induced p38 MAPK tyrosine phosphorylation via the upstream kinases MKK3 or MKK6. Our findings also reveal that the IL-13 receptor-associated tyrosine kinase Jak2 is required for the activation of both Src kinase as well as p38 MAPK. Further, we found that Src tyrosine kinase-mediated activation of p38 MAPK is required for Stat1 and Stat3 serine 727 phosphorylation in alternatively activated monocytes/macrophages. Additional studies identify Hck as the specific Src family member, stimulated by IL-13 and involved in regulating both p38 MAPK activation and p38 MAPK-mediated 15-LO expression. Finally we show that the Hck regulates the expression of other alternative state (M2)-specific genes (Mannose receptor, MAO-A, and CD36) and therefore conclude that Hck acts as a key regulator controlling gene expression in alternatively activated monocytes/macrophages.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878628      PMCID: PMC3196116          DOI: 10.1074/jbc.M111.291492

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase.

Authors:  D J Conrad; H Kuhn; M Mulkins; E Highland; E Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Lipids of human atheroma. 5. The occurrence of a new group of polar sterol esters in various stages of human atherosclerosis.

Authors:  W A Harland; J D Gilbert; G Steel; C J Brooks
Journal:  Atherosclerosis       Date:  1971 Mar-Apr       Impact factor: 5.162

3.  Lipids of human atheroma. 4. Characterisation of a new group of polar sterol esters from human atherosclerotic plaques.

Authors:  C J Brooks; G Steel; J D Gilbert; W A Harland
Journal:  Atherosclerosis       Date:  1971 Mar-Apr       Impact factor: 5.162

4.  Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). II. Functional properties of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions.

Authors:  S M Wahl; I M Katona; B M Stadler; R L Wilder; W E Helsel; L M Wahl
Journal:  Cell Immunol       Date:  1984-05       Impact factor: 4.868

5.  Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis.

Authors:  L M Wahl; I M Katona; R L Wilder; C C Winter; B Haraoui; I Scher; S M Wahl
Journal:  Cell Immunol       Date:  1984-05       Impact factor: 4.868

6.  Epidermal growth factor-stimulated intestinal epithelial cell migration requires Src family kinase-dependent p38 MAPK signaling.

Authors:  Mark R Frey; Anastasia Golovin; D Brent Polk
Journal:  J Biol Chem       Date:  2004-08-16       Impact factor: 5.157

7.  Th2 response of human peripheral monocytes involves isoform-specific induction of monoamine oxidase-A.

Authors:  Pavlos Chaitidis; Ellen E Billett; Valerie B O'Donnell; Alexandra Bermudez Fajardo; Julia Fitzgerald; Ralf J Kuban; Ute Ungethuem; Hartmut Kühn
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

8.  Lipopolysaccharide- and interferon-gamma-induced expression of hck and lyn tyrosine kinases in murine bone marrow-derived macrophages.

Authors:  I Boulet; S Ralph; E Stanley; P Lock; A R Dunn; S P Green; W A Phillips
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

9.  Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages.

Authors:  B K English; J N Ihle; A Myracle; T Yi
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

10.  Augmented expression of a myeloid-specific protein tyrosine kinase gene (hck) after macrophage activation.

Authors:  S F Ziegler; C B Wilson; R M Perlmutter
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  20 in total

1.  From macrophage interleukin-13 receptor to foam cell formation: mechanisms for αMβ2 integrin interference.

Authors:  Valentin P Yakubenko; Linda C Hsi; Martha K Cathcart; Ashish Bhattacharjee
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

2.  Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells.

Authors:  Sukhamoy Dhabal; Pradip Das; Pritam Biswas; Priyanka Kumari; Valentin P Yakubenko; Suman Kundu; Martha K Cathcart; Manjari Kundu; Kaushik Biswas; Ashish Bhattacharjee
Journal:  J Biol Chem       Date:  2018-07-18       Impact factor: 5.157

3.  Monoamine oxidase A (MAO-A): a signature marker of alternatively activated monocytes/macrophages.

Authors:  Martha K Cathcart; Ashish Bhattacharjee
Journal:  Inflamm Cell Signal       Date:  2014

4.  SPLUNC1 deficiency enhances airway eosinophilic inflammation in mice.

Authors:  Jyoti V Thaikoottathil; Richard J Martin; Peter Y Di; Maisha Minor; Stephanie Case; Bicheng Zhang; Gongyi Zhang; Hua Huang; Hong Wei Chu
Journal:  Am J Respir Cell Mol Biol       Date:  2012-04-12       Impact factor: 6.914

5.  Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression.

Authors:  Ashleigh R Poh; Christopher G Love; Frederick Masson; Adele Preaudet; Cary Tsui; Lachlan Whitehead; Simon Monard; Yelena Khakham; Lotta Burstroem; Guillaume Lessene; Oliver Sieber; Clifford Lowell; Tracy L Putoczki; Robert J J O'Donoghue; Matthias Ernst
Journal:  Cancer Cell       Date:  2017-04-10       Impact factor: 31.743

6.  IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages.

Authors:  Ashish Bhattacharjee; Meenakshi Shukla; Valentin P Yakubenko; Anny Mulya; Suman Kundu; Martha K Cathcart
Journal:  Free Radic Biol Med       Date:  2012-11-01       Impact factor: 7.376

7.  Janus kinase 3 activity is necessary for phosphorylation of cytosolic phospholipase A2 and prostaglandin E2 synthesis by macrophages infected with Francisella tularensis live vaccine strain.

Authors:  Ashley M Brummett; Aaron R Navratil; Joshua D Bryan; Matthew D Woolard
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

8.  Hck/Fgr Kinase Deficiency Reduces Plaque Growth and Stability by Blunting Monocyte Recruitment and Intraplaque Motility.

Authors:  Céline Cougoule; Maik Drechsler; Indira Medina; Beatriz Bermudez; Rory R Koenen; Judith Sluimer; Ine Wolfs; Yvonne Döring; Veronica Herias; Marjon Gijbels; Ilze Bot; Saskia de Jager; Christian Weber; Jack Cleutjens; Theo J C van Berkel; Kees-Jan Sikkink; Atilla Mócsai; Isabelle Maridonneau-Parini; Oliver Soehnlein; Erik A L Biessen
Journal:  Circulation       Date:  2015-06-11       Impact factor: 29.690

9.  Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy.

Authors:  Koshi Yamada; Zhi Qiang Huang; Milan Raska; Colin Reily; Joshua C Anderson; Hitoshi Suzuki; Krzysztof Kiryluk; Ali G Gharavi; Bruce A Julian; Christopher D Willey; Jan Novak
Journal:  Kidney Dis (Basel)       Date:  2020-04-16

10.  HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.

Authors:  Zheng Li; Fangce Wang; Xiaoxue Tian; Jun Long; Bin Ling; Wenjun Zhang; Jun Xu; Aibin Liang
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.